PMV Pharmaceuticals, Inc.
PMVP
$1.46
-$0.02-1.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.64% | 24.19% | -19.63% | -1,485.00% | 92.06% |
| Total Depreciation and Amortization | -13.51% | -5.13% | -89.49% | -0.27% | 2.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.01% | -86.24% | 482.83% | -35.38% | 43.54% |
| Change in Net Operating Assets | 224.69% | -206.23% | 22.15% | 157.82% | 5.89% |
| Cash from Operations | -0.20% | -9.63% | 1.06% | -953.75% | 90.13% |
| Capital Expenditure | -175.00% | 92.86% | -5,500.00% | 75.00% | 99.33% |
| Sale of Property, Plant, and Equipment | -- | -- | 665.52% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.81% | 278.97% | -55.66% | 634.46% | -91.30% |
| Cash from Investing | -61.74% | 270.79% | -54.76% | 636.93% | -91.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 930.00% | -94.19% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 930.00% | -94.19% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -114.29% | 163.64% | -375.00% | -33.33% | 117.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.93% | 219.52% | -3,183.10% | -67.43% | -91.23% |